[Cost-utility study of the combination of metformin with the different glucose-lowering medication classes in adults 80 aged and older].

CONCLUSION: Based on this study, the drug combination metformin+DPP-4 inhibitor would be the better therapy in elderly diabetic patient. However, this result needs to be adapted individually. PMID: 31607509 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31607509?dopt=Abstract

Source: Therapie - September 20, 2019 Category: Psychiatry & Psychology Authors: Colombat S, Boulin M Tags: Therapie Source Type: research